id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-317359-7yuygcew	Straccia, Patrizia	Description of a new biosafe procedure for cytological specimens from patients with COVID‐19 processed by liquid‐based preparations	2020-08-07		.txt	text/plain	1782	99	43	CONCLUSIONS: Despite some minor changes in the morphology of the cells, the results of this study highlight that the adoption of the new protocol for the biosafety of LBC‐processed samples in pathology laboratories is important for minimizing the risk for personnel, trainees, and cytopathologists without impairing the diagnostic efficacy of the technique. 8 The new coronavirus, Cancer Cytopathology Month 2020 originally called 2019 novel coronavirus (2019-nCoV) and officially renamed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses, and the disease it causes, namely coronavirus disease 2019 (COVID-19), have quickly become of tremendous concern worldwide. Because the laboratory personnel might be exposed to contamination during the preparation and handling of fresh specimens from such patients, a new procedure for the sterilization of material to be processed by liquid-based cytology (LBC) has been applied.	./cache/cord-317359-7yuygcew.txt	./txt/cord-317359-7yuygcew.txt